Latest Posts

Things To Do At Home

This week, attend an art lecture, listen to a conversation with the novelist Viet Thanh Nguyen or celebrate Deaf History

More top news

Politics

Boris Johnson fails to provide by-election

Boris Johnson’s bid to give his party an electoral boost ahead of a key by-election in North Shropshire hit a

The real story of Boris and

US officials say humanitarian effort in

In case you missed it

Tech

Vinehealth, offering digital support for cancer

Vinehealth, a 2018-founded, London-based digital health startup that’s built an app offering personalized support for cancer patients while also making

Europe’s AI Act falls far short

Boris Johnson fails to provide by-election

Top of the month

zz-top-bassist-and-rock-&-roll-hall-of-fame-inductee-dusty-hill-dead-at-72

ZZ Top members Dusty Hill (L) and Billy Gibbons perform in 2009. (Photo: Reuters/Joshua Roberts) Dusty Hill, bassist and secondary lead vocalist for legendary Southern blues-rock trio ZZ Top, has died, according to a post on the band’s official Facebook page by his bandmates of the past 52 years, Billy

zynga’s-stock-is-getting-slammed-at-least-8-analysts-cut-their-price-targets.

Shares of Zynga were slammed in Friday trading, after the company said some of the gamers it attracted during the pandemic had stopped playing, and that it has began to cost more to find new ones. Zynga (ticker: ZNGA) share plunged 19% to $7.94 in afternoon trading. That positioned the

zynga-stock-is-plunging-after-earnings-here’s-why.

Text size The second-quarter profit was a surprise at mobile-videogame company Zynga, but shares are falling because fewer people are playing. Justin Sullivan/Getty Images Zynga stock plunged in the extended session Thursday, after the company signaled that people were spending less time playing mobile games as the economies in the

zymergen-can-thank-cathie-wood-for-its-head-spinning-rebound

(Bloomberg) — Zymergen Inc. rallied as much as 87% after one of Cathie Wood’s Ark Investment Management LLC funds scooped up its shares. The buying occurred amid Wednesday’s 76% retreat, a record slide that took the synthetic biology company to the lowest since its April debut, after the firm pulled